These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 7887548)

  • 1. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1995 Apr; 122(8):561-8. PubMed ID: 7887548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
    ; Nathan DM; Genuth S; Lachin J; Cleary P; Crofford O; Davis M; Rand L; Siebert C
    N Engl J Med; 1993 Sep; 329(14):977-86. PubMed ID: 8366922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    Ophthalmology; 1995 Apr; 102(4):647-61. PubMed ID: 7724182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).
    The Diabetes Control and Complications Trial Research Group
    Diabetologia; 1998 Apr; 41(4):416-23. PubMed ID: 9562345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1995 Jan; 113(1):36-51. PubMed ID: 7826293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    J Pediatr; 1994 Aug; 125(2):177-88. PubMed ID: 8040759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial.
    Ann Neurol; 1995 Dec; 38(6):869-80. PubMed ID: 8526459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Martin CL; Albers JW; Pop-Busui R;
    Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
    Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial.
    Ann Intern Med; 1996 Feb; 124(4):379-88. PubMed ID: 8554246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    Diabetes; 1988 Apr; 37(4):476-81. PubMed ID: 2897940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced glucose control for preventing and treating diabetic neuropathy.
    Callaghan BC; Little AA; Feldman EL; Hughes RA
    Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD007543. PubMed ID: 22696371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes.
    Ziegler D; Behler M; Schroers-Teuber M; Roden M
    BMJ Open; 2015 Jun; 5(6):e006559. PubMed ID: 26109108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus.
    Kwai N; Arnold R; Poynten AM; Lin CS; Kiernan MC; Krishnan AV
    Diabetes Metab Res Rev; 2015 Feb; 31(2):175-82. PubMed ID: 25066412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Albers JW; Herman WH; Pop-Busui R; Feldman EL; Martin CL; Cleary PA; Waberski BH; Lachin JM;
    Diabetes Care; 2010 May; 33(5):1090-6. PubMed ID: 20150297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Prevalence and Incidence of Diabetic Peripheral Neuropathy in Children and Adolescents With Type 1 Diabetes Mellitus: Results From a Five-Year Prospective Cohort Study.
    Walter-Höliner I; Barbarini DS; Lütschg J; Blassnig-Ezeh A; Zanier U; Saely CH; Simma B
    Pediatr Neurol; 2018 Mar; 80():51-60. PubMed ID: 29429781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.
    Martin CL; Albers J; Herman WH; Cleary P; Waberski B; Greene DA; Stevens MJ; Feldman EL;
    Diabetes Care; 2006 Feb; 29(2):340-4. PubMed ID: 16443884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.